The role of aspirin in women’s health

References

• JackDBA hundred years of aspirinLancet19973504374399259670
   PubMed Web of Science ®Google Scholar
• PatronoCRoccaBAspirin: promise and resistance in the new millenniumArterioscler Thromb Vasc Biol200828s25s3218174450
   PubMed Web of Science ®Google Scholar
• SandlerRSHalabiSBaronJAA randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancerN Engl J Med200334888389012621132
   PubMed Web of Science ®Google Scholar
• BaronJAColeBFSandlerRSA randomized trial of aspirin to prevent colorectal adenomasN Engl J Med200334889189912621133
   PubMed Web of Science ®Google Scholar
• ThunMJHenleySJPatronoCNonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issuesJ Natl Cancer Inst20029425226611854387
   PubMed Web of Science ®Google Scholar
• RothwellPMWilsonMElwinCELong-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of 5 randomised trialsLancet20103761741175020970847
   PubMed Web of Science ®Google Scholar
• CuzickJOttoFBaronJAAspirin and non-steroidal anti- inflammatory drugs for cancer prevention: an international consensus statementLancet Oncol20091050150719410194
   PubMed Web of Science ®Google Scholar
• WallenburgHCDekkerGAMakovitzJWLow-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidaeLancet19861132867260
   PubMed Web of Science ®Google Scholar
• AskieLMDuleyLHenderson-SmartDJAntiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient dataLancet20073691791179817512048
   PubMed Web of Science ®Google Scholar
• DuleyLHenderson-SmartDJMeherSAntiplatelet agents for preventing pre-eclampsia and its complicationsCochrane Database Syst Rev20072CD00465917443552
   PubMed Web of Science ®Google Scholar
• DekkerGSibaiBPrimary, secondary, and tertiary prevention of pre- eclampsiaLancet200135720921511213110
   PubMed Web of Science ®Google Scholar
• ShiSYamazaTAkiyamaKIs Aspirin treatment an appropriate intervention to osteoporosis?Fut Rheumatol2008349950220428329
   PubMedGoogle Scholar
• MarshallTEvaluating national guidelines for prevention of cardiovascular disease in primary careJ Eval Clin Pract20051145246116164586
   PubMed Web of Science ®Google Scholar
• BeckerRCMeadeTWBergerPBThe primary and secondary prevention of coronary artery disease: American College of Chest Physicians Evidence-based Clinical Practice Guidelines (8th Ed)Chest20081336 Suppl776S814S18574278
   PubMed Web of Science ®Google Scholar
• US Preventive Services Task ForceAspirin for the prevention of CVD: US Preventive Services Task Force recommendation statementAnn Intern Med200915039640419293072
   PubMed Web of Science ®Google Scholar
• CannonCPRheeKECaliffRMCurrent use of Aspirin and antithrombotic agents in the United States among outpatients with atherothrombotic disease (from the REduction of Atherothrombosis for Continued Health [REACH] Registry)Am J Cardiol201010544545220152237
   PubMed Web of Science ®Google Scholar
• BergerJSBrownDLBurkeGLAspirin use, dose, and clinical outcomes in postmenopausal women with stable CVD: the Women’s Health Initiative Observational StudyCirc Cardiovasc Qual Outcomes20092788720031819
   PubMed Web of Science ®Google Scholar
• EnriquezJRPratapPZbilutJPWomen tolerate drug therapy for coronary artery disease as well as men do, but are treated less frequently with aspirin, beta-blockers, or statinsGend Med20085536118420166
   PubMedGoogle Scholar
• BrenneckeSPBrownMACrowtherCAAspirin and prevention of preeclampsia. Position statement of the use of low-dose aspirin in pregnancy by the Australasian Society for the Study of Hypertension in PregnancyAust N Z J Obstet Gynaecol19953538417771997
   PubMed Web of Science ®Google Scholar
• VisintinCMugglestoneMAAlmerieMQManagement of hypertensive disorders during pregnancy: summary of NICE guidanceBMJ2010341c220720739360
   PubMed Web of Science ®Google Scholar
• Société française d’anesthésie et de réanimation (Sfar); Collège national des gynécologues et obstétriciens français (CNGOF); Société française de médecine périnatale (SFMP); Société française de néonatalogie (SFNN)Multidisciplinary management of severe pre-eclampsia (PE). Experts’ guidelines 2008. Société française d’anesthésie et de réanimation. Collège national des gynécologues et obstétriciens français. Société française de médecine périnatale. Société française de néonatalogieAnn Fr Anesth Reanim200928275281 French19321292
   PubMedGoogle Scholar
• ChappellLCSeedPEnyeSClinical and geographical variation in prophylactic and therapeutic treatments for pre-eclampsia in the UKBJOG201011769570020175876
   PubMed Web of Science ®Google Scholar
• AHA Women and CVD – Statistics 2010 Available at: http://www.americanheart.org/downloadable/heart/1260905040318FS10WM10.pdfAccessed June 29, 2010
   Google Scholar
• MoscaLMochari-GreenbergerHDolorRJTwelve-year follow-up of American women’s awareness of cardiovascular disease risk and barriers to heart healthCirc Cardiovasc Qual Outcomes2010312012720147489
   PubMed Web of Science ®Google Scholar
• VerheugtFWSmithSCJrThe lady aspirin for cardiovascular diseaseLancet20053661148115016198753
   PubMed Web of Science ®Google Scholar
• RidkerPMCookNRLeeIMA randomized trial of low-dose aspirin in the primary prevention of CVD in womenN Engl J Med20053521293130415753114
   PubMed Web of Science ®Google Scholar
• MansonJEStampferMJColditzGAA prospective study of aspirin use and primary prevention of CVD in womenJAMA19912665215272061978
   PubMed Web of Science ®Google Scholar
• ChanATMansonJEFeskanichDLong-term aspirin use and mortality in womenArch Intern Med200716755625672
   Google Scholar
• Antithrombotic Trialists’ (ATT) CollaborationAspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trialsLancet20093731849186019482214
   PubMed Web of Science ®Google Scholar
• ReevesMJBushnellCDHowardGSex differences in stroke: epidemiology. Clinical presentation, medical care, and outcomesLancet Neurol2008791592618722812
   PubMed Web of Science ®Google Scholar
• KurthTBousserM-GStroke in women: an evolving topicStroke2009401027102819211478
   PubMed Web of Science ®Google Scholar
• PatronoCCollerBGarretAPlatelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic TherapyChest2004126234S264S15383474
   PubMed Web of Science ®Google Scholar
• OgawaHNakayamaMMorimotoTLow-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trialJAMA20083002134214118997198
   PubMed Web of Science ®Google Scholar
• BergerJSRoncaglioniMCAvanziniFAspirin for the primary prevention of cardiovascular events in women and men. A sex-specific meta-analysis of randomized controlled trialsJAMA200629530631316418466
   PubMed Web of Science ®Google Scholar
• HillegassWBDorfmanTAAspirin was cost-effective for primary prevention of cardiovascular events in older women at moderate riskACP J Club20071472417608389
   PubMedGoogle Scholar
• GrevingJPBuskensEKoffijbergHCost-effectiveness of aspirin treatment in the primary prevention of cardiovascular disease events in subgroups based on age, gender, and varying cardiovascular riskCirculation20081172875288318506010
   PubMed Web of Science ®Google Scholar
• PignoneMEarnshawSPletcherMJAspirin for the primary prevention of CVD in women: a cost-utility analysisArch Intern Med200716729029517296886
   PubMed Web of Science ®Google Scholar
• AlgraAGrevingJPAspirin in primary prevention: sex and baseline risk matterLancet20093731821182219482200
   PubMed Web of Science ®Google Scholar
• MoscaLBenjaminEJBerraKEffectiveness-based guidelines for the prevention of cardiovascular disease in women 2011 Update: a guideline from the American Heart AssociationCirculation20111231243126221325087
   PubMed Web of Science ®Google Scholar
• European Stroke OrganisationGuidelines for management of ischemic stroke and transient ischaemic attack 2008Cerebrovasc Dis20082545750718477843
   PubMed Web of Science ®Google Scholar
• De BackerGAmbrosioniEBorch-JohnsenKEuropean guidelines on CVD prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical PracticeEur Heart J2003241601161012964575
   PubMed Web of Science ®Google Scholar
• ZuernCSLindemannSGawazMPlatelet function and response to aspirin: gender-specific features and implications for female thrombotic risk and managementSemin Thromb Hemost20093529530619452405
   PubMed Web of Science ®Google Scholar
• QayyumRBeckerDMYanekLRPlatelet inhibition by aspirin 81 and 325 mg/day in men versus women without clinically apparent cardiovascular diseaseAm J Cardiol20081011359136318435972
   PubMed Web of Science ®Google Scholar
• BeckerDMSegalJVaidyaDSex differences in platelet reactivity and response to low-dose aspirin therapyJAMA20062951420142716551714
   PubMed Web of Science ®Google Scholar
• DuleyLThe global impact of pre-eclampsia and eclampsiaSemin Perinatol20093313013719464502
   PubMed Web of Science ®Google Scholar
• World Health Organization2010Millennium Development Goals Available at: http://www.who.int/topics/millennium_development_goals/maternal_health/en/index.htmlAccessed November 17, 2010
   Google Scholar
• HudaSSFreemanDJNelsonSMShort- and long-term strategies for the management of hypertensive disorders of pregnancyExpert Rev Cardiovasc Ther200971581159419954320
   PubMedGoogle Scholar
• McDonaldSDMalinowskiAZhouQCardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analysesAm Heart J200815691893019061708
   PubMed Web of Science ®Google Scholar
• HarskampREZeemanGCPreeclampsia: at risk for remote cardiovascular diseaseAM J Med Sci200733429129518030186
   PubMed Web of Science ®Google Scholar
• McDonaldSDHanZWalshMWKidney disease after preeclampsia: a systematic review and meta-analysisAm J Kidney Dis2010551026103920346562
   PubMed Web of Science ®Google Scholar
• XuXFDuLZEpigenetics in neonatal diseasesChin Med J (Engl)20101232948295421034612
   PubMed Web of Science ®Google Scholar
• KajantieEErikssonJGOsmondCPre-eclampsia is associated with increased risk of stroke in the adult offspring. The Helsinki Birth Cohort StudyStroke2009401176118019265049
   PubMed Web of Science ®Google Scholar
• GeelhoedJJJaddoeVWEarly influences on cardiovascular and renal developmentEur J Epidemiol20102567769220872047
   PubMed Web of Science ®Google Scholar
• CrispiFComasMHernández-AndradeEDoes pre-eclampsia influence fetal cardiovascular function in early-onset intrauterine growth restriction?Ultrasound Obstet Gynecol20093466066519827117
   PubMed Web of Science ®Google Scholar
• LeducLDuboisETakserLDalteparin and low-dose aspirin in the prevention of adverse obstetric outcomes in women with inherited thrombophiliaJ Obstet Gynaecol Can20072978779317915061
   PubMedGoogle Scholar
• BujoldEMorencyAMRobergeSAcetylsalicylic acid for the prevention of preeclampsia and intra-uterine growth restriction in women with abnormal uterine artery Doppler: a systematic review and meta- analysisJ Obstet Gynaecol Can20093181882619941706
   PubMedGoogle Scholar
• LambersMJGroeneveldEHoozemansDALower incidence of hypertensive complications during pregnancy in patients treated with low-dose aspirin during in vitro fertilization and early pregnancyHum Reprod2009242447245019608566
   PubMed Web of Science ®Google Scholar
• UrbanGVerganiPTironiRAntithrombotic prophylaxis in multiparous women with preeclampsia or intrauterine growth retardation in an antecedent pregnancyInt J Fertil Womens Med200752596718320863
   PubMedGoogle Scholar
• RuanoRFontesRSZugaibMPrevention of preeclampsia with low-dose aspirin – a systematic review and meta-analysis of the main randomized controlled trialsClinics (Sao Paulo)20056040741416254678
   PubMedGoogle Scholar
• EbrashyAIbrahimMMarzookAUsefulness of aspirin therapy in high-risk pregnant women with abnormal uterine artery Doppler ultrasound at 14–16 weeks pregnancy: randomized controlled clinical trialCroat Med J20054682683116158479
   PubMed Web of Science ®Google Scholar
• BujoldERobergeSLacasseYPrevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancyObstet Gynecol201011640241420664402
   PubMed Web of Science ®Google Scholar
• AugustPHelsethGEdersheimTSustained release, low-dose aspirin ameliorates but does not prevent preeclampsia (PE) in a high risk populationProceedings of the 9th International Congress, International Society for the Study of HypertensionMarch 15–18, 1994Sydney, AustraliaHypertension in Pregnancy72
   Google Scholar
• AzarRTurpinDEffect of antiplatelet therapy in women at high risk for pregnancy-induced hypertensionProceedings of 7th World Congress of Hypertension in PregnancyOctober 1990Perugia, Italy257
   Google Scholar
• BeaufilsMUzanSDonsimoniRPrevention of pre-eclampsia by early antiplatelet therapyLancet198518408422858710
   PubMed Web of Science ®Google Scholar
• BenigniAGregoriniGFruscaTEffect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertensionN Engl J Med19893213573622664523
   PubMed Web of Science ®Google Scholar
• HermidaRCAyalaDEIglesiasMTime-dependent effects of low-dose aspirin administration on blood pressure in pregnant womenHypertension1997305895959322987
   PubMed Web of Science ®Google Scholar
• MichaelCAWaltersBNJLow-dose aspirin in the prevention of pre-eclampsia: current evaluationTeohESRatnamSSMacnaughtonMCMaternal physiology and pathology. The current status of gynaecology and obstetrics seriesCarnforth, UKParthenon Publishing Group Ltd1992183189
   Google Scholar
• TulppalaMMarttunenMSoderstrom-AnttilaVLow-dose aspirin in prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect on prostacyclin and thromboxane A2 productionHum Reprod199712156715729262298
   PubMed Web of Science ®Google Scholar
• VainioMKujansuuEIso-MustajarviMLow dose acetylsalicylic acid in prevention of pregnancy-induced hypertension and intrauterine growth retardation in women with bilateral uterine artery notchesBr J Obstet Gynecol2002109161167
   Google Scholar
• DasariRNarangAVasishtaKEffect of maternal low dose aspirin on neonatal platelet functionIndian Pediatr19983550751110216644
   PubMedGoogle Scholar
• HermidaRCAyalaDEFernandezJRAdministration time-dependent effects of aspirin in women at differing risk for preeclampsiaHypertension1999341016102310523401
   PubMed Web of Science ®Google Scholar
• CoomarasamyAHonestHPapaioannouSAspirin for prevention of preeclampsia in women with historical risk factors: a systematic reviewObstet Gynecol20031011319133212798543
   PubMed Web of Science ®Google Scholar
• HermidaRCAyalaDEIglesiasMAdministration time-dependence influence of aspirin on blood pressure in pregnant womenHypertension2003413 Pt 265165612623974
   PubMed Web of Science ®Google Scholar
• CraiciIWagnerSGarovicVDPreeclampsia and future cardiovascular risk: formal risk factor or failed stress test?Ther Adv Cardiovasc Dis2008224925919124425
   PubMedGoogle Scholar
• HertigAWatnickSStevensHHow should women with pre-eclampsia be followed up? New insights from mechanistic studiesNat Clin Pract Nephrol2008450350918628742
   PubMedGoogle Scholar
• MeadsCACnossenJSMeherSMethods of prediction and prevention of pre-eclampsia: systematic reviews of accuracy and effectiveness literature with economic modellingHealth Technol Assess200812iiiiv1270
   Web of Science ®Google Scholar
• Ruiz-IrastorzaGCrowtherMBranchWAntiphospholipid syndromeLancet20103761498150920822807
   PubMed Web of Science ®Google Scholar
• MakACheungMWCheakAACombination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regressionRheumatology (Oxford)20104928128819965971
   PubMed Web of Science ®Google Scholar
• BramhamKHuntBJGermainSPregnancy outcome in different clinical phenotypes of antiphospholipid syndromeLupus201019586419897518
   PubMed Web of Science ®Google Scholar
• ZiakasPDPavlouMVoulgarelisMHeparin treatment in antiphospholipid syndrome with recurrent pregnancy loss: a systematic review and meta-analysisObstet Gynecol20101151256126220502298
   PubMed Web of Science ®Google Scholar
• CohnDMGoddijnMMiddeldorpSRecurrent miscarriage and antiphospholipid antibodies: prognosis of subsequent pregnancyJ Thromb Haemost201082208221320704646
   PubMed Web of Science ®Google Scholar
• LaskinCASpitzerKAClarkCALow molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA trialJ Rheumatol20093627928719208560
   PubMed Web of Science ®Google Scholar
• DendrinosSSakkasEMakrakisELow-molecular-weight heparin versus intravenous immunoglobulin for recurrent abortion associated with antiphospholipid antibody syndromeInt J Gynaecol Obstet200910422322519116178
   PubMed Web of Science ®Google Scholar
• GoelNTuliAChoudhryRThe role of aspirin versus aspirin and heparin in cases of recurrent abortions with raised anticardiolipin antibodiesMed Sci Monit200612CR13213616501426
   PubMed Web of Science ®Google Scholar
• EmpsonMLassereMCraigJPrevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulantCochrane Database Syst Rev200518CD00285915846641
   PubMed Web of Science ®Google Scholar
• BatesSMGreerIAHirshJUse of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic TherapyChest2004126S Suppl627S644S15383488
   PubMed Web of Science ®Google Scholar
• FloodKPeaceAKentEPlatelet reactivity and pregnancy lossAm J Obstet Gynecol2010203281e1e520684942
   PubMed Web of Science ®Google Scholar
• KaandorpSDi NisloMGoddijnMAspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndromeCochrane Database Syst Rev2009CD00473419160241
   PubMed Web of Science ®Google Scholar
• McCartyDJManziSMedsgerTAJrIncidence of systemic lupus erythematosus. Race and gender differencesArthritis Rheum199538126012707575721
   PubMed Web of Science ®Google Scholar
• HaqueSBruceINTherapy insight: systemic lupus erythematosus as a risk factor for cardiovascular diseaseNat Clin Pract Cardiovasc Med2005242343016119705
   PubMedGoogle Scholar
• CostenbaderKHKarlsonEWGallVBarriers to a trial of atherosclerosis prevention in systemic lupus erythematosusArthritis Rheum20055371872316208639
   PubMed Web of Science ®Google Scholar
• MarkowitzSDAspirin and colon cancer-targeting prevention?N Engl J Med20073562195219817522404
   PubMed Web of Science ®Google Scholar
• SchrörKAcetylsalicylic AcidWeinheim, GermanyWiley-Blackwell2009
   Google Scholar
• American Cancer SocietyCancer Facts and Figures 2010Atlanta, GaAmerican Cancer Society2010 Available at: http://www.cancer.org/acs/groups/content/@nho/documents/document/acspc-024113.pdfAccessed November 15, 2010
   Google Scholar
• WeiEKColditzGAGiovannucciELCumulative risk of colon cancer up to age 70 years by risk factor status using data from the Nurses’ Health StudyAm J Epidemiol200917086387219723749
   PubMed Web of Science ®Google Scholar
• HolmesMDChenWYLiLAspirin intake and survival after breast cancerJ Clin Oncol2010281467147220159825
   PubMed Web of Science ®Google Scholar
• BardiaAOlsonJEVachonCMEffect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort studyBreast Cancer Res Treat201112614915520669045
   PubMed Web of Science ®Google Scholar
• McTiernanAWangCYSorensenBNo effect of aspirin on mammographic density in a randomized controlled clinical trialCancer Epidemiol Biomarkers Prev2009181524153019423529
   PubMed Web of Science ®Google Scholar
• ZhaoYSZhuSLiXWAssociation between NSAIDs use and breast cancer risk: a systematic review and meta-analysisBreast Cancer Res Treat200911714115018979210
   PubMed Web of Science ®Google Scholar
• TakkoucheBRegueira-MéndezCEtminanMBreast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysisJ Natl Cancer Inst20081001439144718840819
   PubMedGoogle Scholar
• ZhangSMCookNRMansonJELow-dose aspirin and breast cancer risk: results by tumour characteristics from a randomised trialBr J Cancer20089898999118268496
   PubMed Web of Science ®Google Scholar
• MangiapaneSBlettnerMSchlattmannPAspirin use and breast cancer risk: a meta-analysis and meta-regression of observational studies from 2001 to 2005Pharmacoepidemiol Drug Saf20081711512417955496
   PubMed Web of Science ®Google Scholar
• CookNRLeeIMGazianoJMLow-dose aspirin in the primary prevention of cancer: the Women’s Health Study: a randomized trialJAMA2005294475515998890
   PubMed Web of Science ®Google Scholar
• ViswanathanANFeskanichDSchernhammerESAspirin, NSAID, and acetaminophen use and the risk of endometrial cancerCancer Res2008682507251318381460
   PubMed Web of Science ®Google Scholar